Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Reaching the Brain Through the Groin: A Novel Approach to Brain Cancer

Trending

May 11, 2023
In a new editorial, researchers discuss opening the blood-brain barrier and a promising new strategy for the treatment of brain cancer. continue reading »

Using Cancer Proteomics Data to Identify Gene Candidates for Therapeutic Targeting

News

May 10, 2023
PRESS RELEASE: On May 4, 2023, a new research perspective was published in Oncotarget, entitled, “Using cancer proteomics data to identify gene candidates for therapeutic targeting.” continue reading »

Behind the Study: Role of Biomarkers in Management of Lumps in the Breast

Oncotarget

May 9, 2023
Dr. Georg F. Weber, from the University of Cincinnati Academic Health Center, describes a recent research perspective he authored that was published by Oncotarget in Volume 14, entitled, “Crossroads: the role of biomarkers in the management of lumps in the breast.” continue reading »

LY6 Gene Family: Potential Tumor Antigens and Prognostic Biomarkers in Endometrial Cancer

News

May 8, 2023
PRESS RELEASE: On May 4, 2023, a new research paper was published in Oncotarget, entitled, “Human LY6 gene family: potential tumor-associated antigens and biomarkers of prognosis in uterine corpus endometrial carcinoma.” continue reading »

Systemic AL Amyloidosis: Current Approach and Future Direction

News

May 5, 2023
PRESS RELEASE: On April 26, 2023, a new review paper was published in Oncotarget, entitled, “Systemic AL amyloidosis: current approach and future direction.” continue reading »